S&P 500   2,470.50 (-4.41%)
DOW   20,943.51 (-4.44%)
QQQ   182.31 (-4.25%)
AAPL   240.91 (-5.26%)
FB   159.60 (-4.32%)
MSFT   152.11 (-3.55%)
GOOGL   1,102.10 (-5.15%)
AMZN   1,907.70 (-2.16%)
CGC   13.58 (-5.83%)
NVDA   243.07 (-7.79%)
BABA   187.56 (-3.56%)
MU   39.89 (-5.16%)
GE   7.04 (-11.34%)
TSLA   481.56 (-8.10%)
AMD   43.66 (-4.00%)
T   28.05 (-3.77%)
ACB   0.81 (-11.00%)
F   4.40 (-8.90%)
NFLX   364.08 (-3.04%)
BAC   19.77 (-6.88%)
GILD   72.51 (-3.01%)
PRI   84.16 (-4.88%)
DIS   94.92 (-1.74%)
S&P 500   2,470.50 (-4.41%)
DOW   20,943.51 (-4.44%)
QQQ   182.31 (-4.25%)
AAPL   240.91 (-5.26%)
FB   159.60 (-4.32%)
MSFT   152.11 (-3.55%)
GOOGL   1,102.10 (-5.15%)
AMZN   1,907.70 (-2.16%)
CGC   13.58 (-5.83%)
NVDA   243.07 (-7.79%)
BABA   187.56 (-3.56%)
MU   39.89 (-5.16%)
GE   7.04 (-11.34%)
TSLA   481.56 (-8.10%)
AMD   43.66 (-4.00%)
T   28.05 (-3.77%)
ACB   0.81 (-11.00%)
F   4.40 (-8.90%)
NFLX   364.08 (-3.04%)
BAC   19.77 (-6.88%)
GILD   72.51 (-3.01%)
PRI   84.16 (-4.88%)
DIS   94.92 (-1.74%)
S&P 500   2,470.50 (-4.41%)
DOW   20,943.51 (-4.44%)
QQQ   182.31 (-4.25%)
AAPL   240.91 (-5.26%)
FB   159.60 (-4.32%)
MSFT   152.11 (-3.55%)
GOOGL   1,102.10 (-5.15%)
AMZN   1,907.70 (-2.16%)
CGC   13.58 (-5.83%)
NVDA   243.07 (-7.79%)
BABA   187.56 (-3.56%)
MU   39.89 (-5.16%)
GE   7.04 (-11.34%)
TSLA   481.56 (-8.10%)
AMD   43.66 (-4.00%)
T   28.05 (-3.77%)
ACB   0.81 (-11.00%)
F   4.40 (-8.90%)
NFLX   364.08 (-3.04%)
BAC   19.77 (-6.88%)
GILD   72.51 (-3.01%)
PRI   84.16 (-4.88%)
DIS   94.92 (-1.74%)
S&P 500   2,470.50 (-4.41%)
DOW   20,943.51 (-4.44%)
QQQ   182.31 (-4.25%)
AAPL   240.91 (-5.26%)
FB   159.60 (-4.32%)
MSFT   152.11 (-3.55%)
GOOGL   1,102.10 (-5.15%)
AMZN   1,907.70 (-2.16%)
CGC   13.58 (-5.83%)
NVDA   243.07 (-7.79%)
BABA   187.56 (-3.56%)
MU   39.89 (-5.16%)
GE   7.04 (-11.34%)
TSLA   481.56 (-8.10%)
AMD   43.66 (-4.00%)
T   28.05 (-3.77%)
ACB   0.81 (-11.00%)
F   4.40 (-8.90%)
NFLX   364.08 (-3.04%)
BAC   19.77 (-6.88%)
GILD   72.51 (-3.01%)
PRI   84.16 (-4.88%)
DIS   94.92 (-1.74%)
Log in

Vertex Pharmaceuticals News Headlines (NASDAQ:VRTX)

$225.48
-12.47 (-5.24 %)
(As of 04/1/2020 04:00 PM ET)
Today's Range
$223.45
Now: $225.48
$234.98
50-Day Range
$199.77
MA: $228.49
$247.81
52-Week Range
$163.68
Now: $225.48
$249.85
Volume1.48 million shs
Average Volume1.85 million shs
Market Capitalization$58.46 billion
P/E Ratio50.00
Dividend YieldN/A
Beta1.32

Headlines

Vertex Pharmaceuticals (NASDAQ VRTX) News Headlines

Source:
DateHeadline
3 Drugmakers Still Worth Betting on Amid Coronavirus Woes3 Drugmakers Still Worth Betting on Amid Coronavirus Woes
finance.yahoo.com - April 1 at 3:30 PM
Nasdaq 100 Movers: AAL, VRTXNasdaq 100 Movers: AAL, VRTX
www.nasdaq.com - March 30 at 8:49 PM
Vertex to Halt Enrollment Due to Coronavirus, Keeps Sales ViewVertex to Halt Enrollment Due to Coronavirus, Keeps Sales View
finance.yahoo.com - March 30 at 8:49 PM
$1.25 Billion in Sales Expected for Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) This Quarter$1.25 Billion in Sales Expected for Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) This Quarter
www.americanbankingnews.com - March 30 at 1:56 AM
Zacks: Analysts Expect Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Will Announce Earnings of $1.77 Per ShareZacks: Analysts Expect Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Will Announce Earnings of $1.77 Per Share
www.americanbankingnews.com - March 28 at 9:38 PM
Piper Sandler Reaffirms "Buy" Rating for Vertex Pharmaceuticals (NASDAQ:VRTX)Piper Sandler Reaffirms "Buy" Rating for Vertex Pharmaceuticals (NASDAQ:VRTX)
www.americanbankingnews.com - March 28 at 6:50 AM
Vertex Pharmaceuticals to Pause Some Clinical TrialsVertex Pharmaceuticals to Pause Some Clinical Trials
www.fool.com - March 27 at 2:58 PM
First Week of May 15th Options Trading For Vertex Pharmaceuticals (VRTX)First Week of May 15th Options Trading For Vertex Pharmaceuticals (VRTX)
www.nasdaq.com - March 27 at 2:58 PM
Vertex Pharma says supply chain OKVertex Pharma says supply chain OK
seekingalpha.com - March 27 at 9:57 AM
VertexVertex
finance.yahoo.com - March 26 at 5:51 PM
IBD Stock Of The Day: Why Coronavirus Isn't Slamming This Biotech LeaderIBD Stock Of The Day: Why Coronavirus Isn't Slamming This Biotech Leader
finance.yahoo.com - March 23 at 7:43 PM
Local companies, foundations scramble to help nonprofits in needLocal companies, foundations scramble to help nonprofits in need
finance.yahoo.com - March 20 at 7:24 AM
Nasdaq Starts New Rally Attempt With Bullish GainNasdaq Starts New Rally Attempt With Bullish Gain
finance.yahoo.com - March 19 at 8:07 PM
Vertex Shows Relative StrengthVertex Shows Relative Strength
finance.yahoo.com - March 19 at 8:07 PM
Vertex Confirms 20% Revenue Growth Forecast, Presents A Compelling Investment OpportunityVertex Confirms 20% Revenue Growth Forecast, Presents A Compelling Investment Opportunity
seekingalpha.com - March 19 at 3:06 PM
Vertex Pharmaceuticals (VRTX) Gains As Market Dips: What You Should KnowVertex Pharmaceuticals (VRTX) Gains As Market Dips: What You Should Know
finance.yahoo.com - March 18 at 7:20 PM
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Receives Consensus Rating of "Buy" from AnalystsVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Receives Consensus Rating of "Buy" from Analysts
www.americanbankingnews.com - March 18 at 7:07 AM
Why Biogen, GW Pharmaceuticals, and Vertex Pharmaceuticals Stocks Jumped TodayWhy Biogen, GW Pharmaceuticals, and Vertex Pharmaceuticals Stocks Jumped Today
www.fool.com - March 17 at 5:22 PM
The Zacks Analyst Blog Highlights: Regeneron Pharmaceuticals, Co-Diagnostics, Moderna and Vertex PharmaceuticalsThe Zacks Analyst Blog Highlights: Regeneron Pharmaceuticals, Co-Diagnostics, Moderna and Vertex Pharmaceuticals
finance.yahoo.com - March 17 at 1:14 PM
Zacks.com featured highlights include: Fabrinet, Lumentum, Daqo New Energy and Vertex PharmaceuticalsZacks.com featured highlights include: Fabrinet, Lumentum, Daqo New Energy and Vertex Pharmaceuticals
finance.yahoo.com - March 17 at 1:14 PM
Here are the BBJs Business of Pride LGBT award honoreesHere are the BBJ's Business of Pride LGBT award honorees
www.bizjournals.com - March 17 at 12:11 AM
First Week of May 1st Options Trading For Vertex Pharmaceuticals (VRTX)First Week of May 1st Options Trading For Vertex Pharmaceuticals (VRTX)
www.nasdaq.com - March 17 at 12:11 AM
Here are the BBJ's Business of Pride LGBT award honoreesHere are the BBJ's Business of Pride LGBT award honorees
finance.yahoo.com - March 16 at 2:10 PM
Coronavirus Bear Market: All Stocks Are Under Quarantine, But Keep Vertex, Biogen, Dexcom, Eli Lilly, Masimo Under ObservationCoronavirus Bear Market: All Stocks Are Under Quarantine, But Keep Vertex, Biogen, Dexcom, Eli Lilly, Masimo Under Observation
finance.yahoo.com - March 14 at 8:54 AM
Vertex donates $500k to Partners HealthCare for coronavirus testingVertex donates $500k to Partners HealthCare for coronavirus testing
finance.yahoo.com - March 13 at 1:34 PM
Geron's (GERN) Q4 Earnings and Revenues Surpass EstimatesGeron's (GERN) Q4 Earnings and Revenues Surpass Estimates
finance.yahoo.com - March 13 at 1:34 PM
The Vertex Foundation Donates $500,000 to Partners HealthCare to Support COVID-19 Outbreak ResponseThe Vertex Foundation Donates $500,000 to Partners HealthCare to Support COVID-19 Outbreak Response
finance.yahoo.com - March 13 at 8:33 AM
Sustainability Investing Drives This Putnam Fund's OutperformanceSustainability Investing Drives This Putnam Fund's Outperformance
finance.yahoo.com - March 13 at 8:33 AM
Vertex Pharmaceuticals (NASDAQ:VRTX) Earns Outperform Rating from Analysts at Wolfe ResearchVertex Pharmaceuticals (NASDAQ:VRTX) Earns Outperform Rating from Analysts at Wolfe Research
www.americanbankingnews.com - March 12 at 5:07 PM
Hedge Funds Piled Into Vertex Pharmaceuticals (VRTX) Just In TimeHedge Funds Piled Into Vertex Pharmaceuticals (VRTX) Just In Time
finance.yahoo.com - March 11 at 11:06 PM
Should You Be Pleased About The CEO Pay At Vertex Pharmaceuticals Incorporateds (NASDAQ:VRTX)Should You Be Pleased About The CEO Pay At Vertex Pharmaceuticals Incorporated's (NASDAQ:VRTX)
finance.yahoo.com - March 11 at 6:05 PM
3 Charts Suggest Traders Will Remain Bullish on Biotech3 Charts Suggest Traders Will Remain Bullish on Biotech
finance.yahoo.com - March 11 at 1:04 PM
Should You Be Pleased About The CEO Pay At Vertex Pharmaceuticals Incorporated's (NASDAQ:VRTX)Should You Be Pleased About The CEO Pay At Vertex Pharmaceuticals Incorporated's (NASDAQ:VRTX)
finance.yahoo.com - March 11 at 1:04 PM
Cantor Fitzgerald Reiterates "Overweight" Rating for Vertex Pharmaceuticals (NASDAQ:VRTX)Cantor Fitzgerald Reiterates "Overweight" Rating for Vertex Pharmaceuticals (NASDAQ:VRTX)
www.americanbankingnews.com - March 11 at 8:19 AM
Vertex backs 2020 forecastVertex backs 2020 forecast
seekingalpha.com - March 9 at 12:45 PM
Stocks nosedive as coronavirus cases surpass 100KStocks nosedive as coronavirus cases surpass 100K
finance.yahoo.com - March 8 at 8:37 PM
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Expected to Announce Quarterly Sales of $1.25 BillionVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Expected to Announce Quarterly Sales of $1.25 Billion
www.americanbankingnews.com - March 7 at 2:50 AM
5 Top Stocks With Great Earnings Beat Potential5 Top Stocks With Great Earnings Beat Potential
finance.yahoo.com - March 3 at 9:26 AM
Vertex Announces Cancellation of its March 3 Presentation at the Cowen Health Care ConferenceVertex Announces Cancellation of its March 3 Presentation at the Cowen Health Care Conference
finance.yahoo.com - March 2 at 6:09 PM
Biotech outlook amid race to develop coronavirus vaccineBiotech outlook amid race to develop coronavirus vaccine
finance.yahoo.com - February 29 at 2:17 PM
Why Is Vertex (VRTX) Down 2.7% Since Last Earnings Report?Why Is Vertex (VRTX) Down 2.7% Since Last Earnings Report?
finance.yahoo.com - February 29 at 2:17 PM
Vertex to Present at the Cowen Health Care Conference on March 3Vertex to Present at the Cowen Health Care Conference on March 3
www.marketwatch.com - February 25 at 5:54 PM
Looking for a Growth Stock? Why It is Time to Focus on Vertex (VRTX)Looking for a Growth Stock? Why It is Time to Focus on Vertex (VRTX)
finance.yahoo.com - February 24 at 1:43 PM
3 Reasons Why Vertex (VRTX) Is a Great Growth Stock3 Reasons Why Vertex (VRTX) Is a Great Growth Stock
finance.yahoo.com - February 24 at 1:43 PM
Surging Earnings Estimates Signal Good News for Vertex Pharmaceuticals (VRTX)Surging Earnings Estimates Signal Good News for Vertex Pharmaceuticals (VRTX)
finance.yahoo.com - February 20 at 2:07 PM
Better Buy: Vertex Pharmaceuticals vs. IncyteBetter Buy: Vertex Pharmaceuticals vs. Incyte
www.fool.com - February 19 at 12:52 PM
Stock Alert: VRTX Trading Close To 52-Week HighStock Alert: VRTX Trading Close To 52-Week High
www.nasdaq.com - February 19 at 8:16 AM
Blood disorder startup files for $86M IPOBlood disorder startup files for $86M IPO
finance.yahoo.com - February 19 at 8:16 AM
Vertex's Cystic Fibrosis Franchise and Healthy Pipeline Support a Narrow Moat RatingVertex's Cystic Fibrosis Franchise and Healthy Pipeline Support a Narrow Moat Rating
finance.yahoo.com - February 18 at 1:40 PM
Whats in Store for Vertex in 2020 After a Remarkable 2019?What's in Store for Vertex in 2020 After a Remarkable 2019?
finance.yahoo.com - February 14 at 1:47 PM
This page was last updated on 4/1/2020 by MarketBeat.com Staff

Featured Article: Neutral Rating

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel